Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Exercise or conversion President and CEO acquired 5,000 shares (option exercise)
  2. 4 Exercise or conversion VP and CFO acquired 4,000 shares (option exercise)
  3. 4 Exercise or conversion VP Bus Dev & Con Mfg acquired 2,500 shares (option exercise)
  4. 4 Grant or award President and CEO acquired 15,000 shares (grant or award)
  5. 4 Grant or award Vice President and CFO acquired 4,200 shares (grant or award)
  6. 4 Grant or award Director acquired 800 shares (grant or award)
  7. 4 Grant or award VP Bus Dev & Con Mfg acquired 3,000 shares (grant or award)
  8. 4 Grant or award Vice President, Operations acquired 1,500 shares (grant or award)
  9. 4 Grant or award Director acquired 800 shares (grant or award)
  10. 4 Grant or award Director acquired 800 shares (grant or award)
  11. 4 Grant or award Director acquired 800 shares (grant or award)
  12. 4 Grant or award Director acquired 800 shares (grant or award)
  13. 4 Open-market sale Vice President, Operations sold 15,000 shares at $66.50 ($997,500)
  14. 4 Open-market sale Director sold 210,000 shares at $63.00 ($13,230,000)
  15. 4 Open-market sale Vice President and CFO sold 45,000 shares at $63.00 ($2,835,000)
  16. 4 Open-market sale President and CEO sold 75,000 shares at $63.00 ($4,725,000)
  17. 4 Open-market sale 10% owner sold 300,000 shares at $63.00 ($18,900,000)
  18. 4 Open-market sale Director sold 200,000 shares at $63.00 ($12,600,000)
  19. 4 Open-market buy Director bought 3,000 shares at $27.49 ($82,477)
  20. 4 Open-market buy President and CEO bought 1,000 shares at $26.50 ($26,500)

Page 26 of 42 · 835 filings